Continuous Epidural Analgesia Versus Continuous Supra-Inguinal Fascia Iliaca Block in Total Hip Replacement Surgery (S-FICB)
Postoperative Pain
About this trial
This is an interventional treatment trial for Postoperative Pain
Eligibility Criteria
Inclusion Criteria:
- orthopaedic patients, American Society of Anesthesiologists (ASA) physical status I-III, scheduled to undergo unilateral total hip replacement surgery via lateral approach
Exclusion Criteria:
1- History of neurological/neuromuscular, psychiatric disease, dementia preventing proper comprehension.
2- Patients younger than 18 years or older than 80 years. 3- Patients with Body Mass Index (BMI) <18.5 or >30 kg/m2. 4- Coagulation disturbances (INR>1.4, platelet count<100 000). 5- History of opioid dependence (opioid use within the last 4 weeks). 6- History of allergies to study medications. 7- Other contraindications to neuraxial blockade (e.g., patient refusal, local/systemic sepsis, low fixed cardiac output).
8- Contraindications to continuous fascia iliaca compartment block (e.g., infection overlying the injection site or previous femoro-popliteal bypass surgery).
Sites / Locations
- Alexandria faculty of medicineRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
continuous epidural analgesia
continuous supra-inguinal fascia iliaca compartment block
continuous lumbar epidural catheter inserted preoperatively before induction of general anaesthesia
ultrasound guided supra-inguinal FICB with insertion of catheter for continuous infusion before induction of general anaesthesia.